Fatigue More Common in Progressive MS Patients, Survey Shows

Fatigue More Common in Progressive MS Patients, Survey Shows

Fatigue is more prevalent among patients with progressive multiple sclerosis (MS), according to a study that surveyed patients on fatigue and factors related to it.

In addition, increased fatigue severity correlated with greater physical, cognitive, and psychological impairment, although the strength of this link was largely the same between progressive and non-progressive MS patients.

The study, “Prevalence of fatigue and its association with clinical features in progressive and non-progressive forms of Multiple Sclerosis,” was published in the journal Multiple Sclerosis and Related Disorders.

Fatigue, defined in the study as “a subjective lack of physical and/or mental energy that is perceived by the individual or caregiver to interfere with usual and desired activities,” is often regarded as the most debilitating symptom of MS.

Estimates indicate that between 52 percent and 88 percent of MS patients report fatigue. Differences in study populations, outcome measures, and methods used to identify people with or without fatigue explain the large disparity in the reported prevalence of the condition between studies.

Discuss the latest research in the MS News Today forums!

It is unclear how exactly MS causes fatigue, with some evidence suggesting it is a direct consequence of disease-related processes, including inflammation and brain damage. Similarly, there is research showing that fatigue can develop independently of MS, due to depression or disability; however, this research is inconsistent.

Additionally, few studies have considered the relationship between fatigue and sleep quality or cognition symptoms common in MS patients, which have been proposed to contribute to its development.

Although fatigue seems to be more prevalent in progressive forms of MS, few studies have considered its association with clinical features specifically in patients with primary– or secondary-progressive MS.

To try and better understand the link between MS and fatigue, researchers from Glasgow Caledonian University in Scotland analyzed the prevalence of self-reported fatigue among patients with progressive or non-progressive MS, and attempted to evaluate the relationship between fatigue severity and impact and clinical features of the disease.

The team collected data using an online survey that was made accessible via a link distributed to potential participants by national and international MS charities and organizations based in the U.S., U.K., and Australia. Inclusion criteria for participating in the survey was a medical diagnosis of MS and a minimum age of 18 years.

In the survey, which took about 30 to 40 minutes to complete, participants self-reported demographic information (including MS type and disability level). They also completed a series of patient-reported outcome measures related to MS impact, quality of life, depression and anxiety, cognition, and sleep. Fatigue severity was assessed using the Fatigue Severity Scale.

In total, the team analyzed 412 participants, of whom 111 reported having a progressive form of MS, whereas 301 reported having a non-progressive form. Of these patients, 308 provided complete survey responses.

Results showed that fatigue was a prevalent symptom, reported by 68.7% of the participants. A higher proportion of participants with progressive MS (81.1%) reported fatigue, compared with those with non-progressive forms of MS (64.1%), confirming the evidence from previous studies that the condition is more prevalent among patients with progressive forms of the disease.

Researchers also found a link between fatigue and MS clinical features, namely that both fatigue severity and impact were associated with higher levels of disability, poorer quality of life, greater depression and anxiety, and poor cognition and sleep quality.

The link between fatigue severity or impact and clinical features was similar between both progressive and non-progressive MS patients.

“Fatigue was more prevalent amongst participants with progressive MS. In addition, higher fatigue severity and impact were associated with greater physical, cognitive, and psychological impairment, although the strength of association between these outcomes was generally similar regardless of the type of MS,” the researchers concluded.

These findings emphasize the multifactorial nature of fatigue in MS and, according to the team, highlight the importance of designing and evaluating interventions aimed at alleviating fatigue in these patients.

3 comments

  1. Lynne Robertson says:

    If I could end the fatigue, my MS and subsequent disabilities and impairments would all be totally manageable. Please, please find a cure to end the fatigue. Better still please make HSCT an available treatment option on the NHS as everyone who has had it in the trials or had this treatment abroad reports an instant cessation in fatigue and disease progression. If you live in scotland this option is not available but if you go to England it is an option if you meet the criteria. Please catch up with Moscow and Mexico who have treated hundreds of MS sufferers with HSCT and ended the disease progression and cured the fatigue in both RR and PP. It is only £40,000 to have done and yet the drugs I was on costed the NHS £15,000 per annum. Just think what this would do to reduce the costs in the long term if at diagnosis you were sent for immediate HSCT treatment. I am Progressive Relapsing – the most rarely discussed or studied form and as the name suggests it combines both of the common types of MS. Please make HSCT an available treatment.

  2. Christina I Wilson says:

    the closest I have found in recognizable parallel circumstances is the fatigue from radiation therapy that happens, slowly creeps in and wipes your slate for undisclosed and extended time after an event or stressful time. It’s like pajama days with daytime pajamas and nighttime pajamas and getting comfortable with long periods under the covers. Not depression, just inability to move despite all the good intentions, having the electrical cord of ability pulled out from under without permission. I hear they research recovery time in older populations, and maybe it’s an idea for MS. Breaking through the overwhelming, cloaking fatigue with forced exercise, albeit extremely small through a YMCA post cancer exercise group/moving support group has seriously helped me recover places I lost. Cancer was the best thing for me as I found a group of people with services and acceptance for what I could do, regardless of my position at the bottom of the group in speed. I also found some recovery in fatigue when I watched my daughters play hockey in an ice rink and used the cold to identify and treat the inflammed pieces of my body: a fused ankle, a fused lower back, tweaks of muscles hardened like rock in my upper back and neck, and I walked out of the game after sitting on bench with back against concrete cold wall and I had clearer head and quicker, less wobbly, still wide gait. Thank you for looking into these elusive pieces of MS

  3. Denise Anger says:

    I agree with first post hsct should be widely available as it stops progression and in the long run would save thousands on medication its a no brainer and should be done as early as possible before dissabilitu worsens.

Leave a Comment

Your email address will not be published. Required fields are marked *

Pin It on Pinterest

Share This